Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients
Júlia C.F. Quintanilha, Federico Innocenti(AbbVie (United States)), Howard L. McLeod(Unknown), Amy S. Etheridge(University of North Carolina at Chapel Hill), Elizabeth Claire Dees(University of North Carolina at Chapel Hill), Jai N. Patel(Levine Cancer Institute), Monica M. Bertagnolli(National Institutes of Health), Alexander B. Sibley(Duke University), Kouros Owzar(Duke University), Flora Mulkey(Sherwin Williams (United States)), Deanna L. Kroetz(University of California, San Francisco), D. Y. Lin(University of North Carolina at Chapel Hill), Mark J. Ratain(University of Chicago), Daniel L. Hertz(GTx (United States)), Fei Shen(Indiana University Health), Hedy L. Kindler(University of Chicago), Hope S. Rugo(City of Hope), Jin Wang(East China University of Science and Technology), Chen Jiang, Guanglong Jiang(Indiana University – Purdue University Indianapolis), William Kevin Kelly(Thomas Jefferson University), Bryan P. Schneider(Shanghai University of Traditional Chinese Medicine)
Cited by 24
Related Papers
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k